1 unknown, 1 withdrawn. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Unknown 1 |
Follow ethanolamine oleate: new trials by email Literature Review of ethanolamine oleate trials Research Report on ethanolamine oleate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection Injection Sclerotherapy, N-butyl-2-cyanoacrylate - Bleeding Esophageal Varices | Phase 3 | Unknown | Sherief Abd-Elsalam | 113 | 2016-01-01 | 2018-04-24 |
| Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies Edetate Calcium Disodium, Ethanol, Trimethoprim-sulfamethoxazole - Chronic Myeloproliferative Disorders, Infection | Phase 1 / Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2013-02-15 |
Blast Crisis (1) · Burkitt Lymphoma (1) · Congenital Abnormalities (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Immunoglobulin Light-chain Amyloidosis (1) · Infections (1) · Intraocular Lymphoma (1) · Leukemia (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Hairy Cell (1) · Leukemia, Large Granular Lymphocytic (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Mast-Cell (1) · Leukemia, Myeloid, Accelerated Phase (1)
M.D. Anderson Cancer Center (1) · Sherief Abd-Elsalam (1)
Egypt (1)
Jorge Cortes, MD (1) · Mohamed Abdelraouf, MD (1) · Mohamed Alsebaey, MD (1) · Patrick Chaftari, MD (1) · Sherief Abd-Elsalam, MD (1)